Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
7(44%)
Results Posted
67%(4 trials)

Phase Distribution

Ph not_applicable
1
6%
Ph phase_1
6
38%
Ph phase_2
4
25%
Ph phase_3
4
25%

Phase Distribution

6

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
6(40.0%)
Phase 2Efficacy & side effects
4(26.7%)
Phase 3Large-scale testing
4(26.7%)
N/ANon-phased studies
1(6.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

16

all time

Status Distribution
Active(9)
Completed(6)
Other(1)

Detailed Status

Recruiting7
Completed6
Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
7
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (40.0%)
Phase 24 (26.7%)
Phase 34 (26.7%)
N/A1 (6.7%)

Trials by Status

not_yet_recruiting213%
recruiting744%
completed638%
unknown16%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT06627309

Rapid dFLC Response Predict CHR in AL Amyloidosis

Recruiting
NCT06854250Phase 2

Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer

Recruiting
NCT07131085Phase 1

QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)

Not Yet Recruiting
NCT07120607Phase 1

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

Not Yet Recruiting
NCT06802315Phase 2

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Recruiting
NCT06594640Phase 1

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Recruiting
NCT06773091Phase 1

A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors

Recruiting
NCT06809699Phase 1

Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation

Recruiting
NCT06809712Phase 1

Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

Recruiting
NCT01850108Not Applicable

Non-Myeloablative Conditioning and Bone Marrow Transplantation

Unknown
NCT02566993Phase 3

Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer

Completed
NCT00671658Phase 2

Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

Completed
NCT02256150Phase 3

A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

Completed
NCT02257697Phase 3

A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome

Completed
NCT00002836Phase 3

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

Completed
NCT00890656Phase 2

Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16